Quantcast

Latest Benzimidazoles Stories

2011-04-05 09:30:00

NEW ORLEANS, April 5, 2011 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. (Takeda) announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors (PPIs) on Plavix (clopidogrel bisulfate). The results showed that in healthy subjects, clopidogrel's active metabolite and inhibition of platelet function were reduced less by the co-administration of clopidogrel with dexlansoprazole or lansoprazole, rather than...

2011-02-14 09:00:00

CHAPEL HILL, N.C., Feb. 14, 2011 /PRNewswire/ -- Thought Leader Select, a Research Triangle, NC firm focused on collaborations between the biopharmaceutical industry and the medical community, announces the launch of a new media partnership with biopharmaceutical industry blog Marketing4Health. The research and consulting firm (Thought Leader Select) has signed on to become the blog's exclusive sponsor, beginning February 14, 2011. With a growing international following and strong...

2011-01-19 13:38:00

RADNOR, Pa., Jan. 19, 2011 /PRNewswire/ -- HTH Worldwide, a global health and safety services company, today announced the expansion of its mobile and online brand name medication translation guide for world travelers. Prescription and over-the-counter drug names often vary by country -- for example Prilosec is called Lomac or Prilosid in India -- so those traveling, living or studying abroad need to be sure they are getting the precise equivalent of medications they were prescribed at...

2011-01-05 07:00:00

RIDGEFIELD, Conn., Jan. 5, 2011 /PRNewswire/ -- Results of a post-hoc analysis of the RE-LY® trial among patients with non-valvular atrial fibrillation (NVAF) undergoing cardioversion, a treatment to convert an abnormal heartbeat back to normal sinus rhythm, were published online on Jan. 3 in Circulation.(1) Stroke and systemic embolism and major bleeding episodes within 30 days of the cardioversion were the major outcome measures. The analysis reported that rates of...

2010-11-25 21:43:30

Despite the reassurances of Pasternak and Hviid in their study, "Use of Proton-Pump Inhibitors (PPI) in Early Pregnancy and the Risk of Birth Defects," featured in the Nov. 24 issue of the New England Journal of Medicine, an epidemiologist from Boston University School of Medicine (BUSM) believes that further studies are needed. The original study found that on the basis of data from more than 840,000 live births in Denmark, there was no evidence to suggest that the use of the most common...

2010-11-05 10:51:10

(Ivanhoe Newswire) -- The recent approval of a drug may be a cost-effective way to prevent stroke in patients with an irregular heart rhythm. It may also offer patient's better health outcomes than the commonly prescribed and potentially risky blood thinner, warfain. "Dabigatran is the first new drug in 20 years to be approved for stroke prevention in atrial fibrillation, and we wanted to see if it could be cost-effective even before it made its debut in the United States," cardiac...

2010-11-01 16:06:00

RIDGEFIELD, Conn., Nov. 1, 2010 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that its new oral anticoagulant, Pradaxa® (dabigatran etexilate mesylate) 150mg capsules, will be available starting Wednesday by prescription in pharmacies across the United States, including CVS/pharmacy, Rite Aid, Walmart, Target, Kmart® and The Kroger Co. In addition, leading independents under the Health Mart®, Good Neighbor...

2010-10-26 07:00:00

CINCINNATI, Oct. 26 /PRNewswire/ -- Celebrating the return of the NFL season, Prilosec OTC® - the #1 pharmacist recommended over-the-counter heartburn medicine according to Pharmacy Times - has teamed up with two of the NFL's toughest offensive lineman to showcase the importance of powerful protection when it comes to treating frequent heartburn. New York Giants All-Pro Offensive Tackle David Diehl and Minnesota Vikings Guard Anthony Herrera have teamed up with Prilosec...

2010-10-19 19:15:00

RIDGEFIELD, Conn., Oct. 19 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate) capsules to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AFib).(1) PRADAXA, an oral direct thrombin inhibitor(2) that was discovered and developed by Boehringer Ingelheim, is the first new oral anticoagulant approved in the U.S. in more than 50 years. As demonstrated in the...

2010-09-22 11:29:00

DEXILANT is the First Proton Pump Inhibitor (PPI) with a DUAL DELAYED RELEASE (DDR) Technology MISSISSAUGA, ON, Sept. 22 /PRNewswire/ - To view this Social Media Release, please enter the following address in your web browser. http://smr.newswire.ca/en/takeda-canada-inc/patients-living-with-gerd-now-have-a-new-treatment SOURCE Takeda Canada Inc.


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.